Characterization of 4-Aminopyridine in Overdose
- 1 January 1994
- journal article
- research article
- Published by Taylor & Francis in Journal of Toxicology: Clinical Toxicology
- Vol. 32 (5) , 583-587
Abstract
We report three cases of 4-aminopyridine overdose resulting in seizure activity. All patients were on therapeutic regimens for the treatment of multiple sclerosis. All patients were responsive to intensive supportive care, although the length of toxicity was prolonged more than 24 hours in one patient. Seizure activity was responsive to benzodiazepine and phenytoin therapy.Keywords
This publication has 20 references indexed in Scilit:
- 4-Aminopyridine in Patients with Multiple SclerosisClinical Neuropharmacology, 1993
- The effect of 4‐aminopyridine on clinical signs in multiple sclerosis: A randomized, placebo‐controlled, double‐blind, cross‐over studyAnnals of Neurology, 1992
- Increased Visual Impairment after Exercise (Uhthoff’s Phenomenon) in Multiple Sclerosis: Therapeutic PossibilitiesEuropean Neurology, 1992
- 4‐Aminopyridine in multiple sclerosisNeurology, 1991
- Preliminary trial of 3,4‐diaminopyridine in patients with multiple sclerosisAnnals of Neurology, 1990
- THE MYASTHENIC SYNDROME: ANAESTHESIA IN A PATIENT TREATED WITH 3.4 DIAMINOPYRIDINEBritish Journal of Anaesthesia, 1990
- Orally administered 4‐aminopyridine improves clinical signs in multiple sclerosisAnnals of Neurology, 1990
- Effects of 4‐aminopyridine in experimental CNS demyelinationNeurology, 1988
- 4‐Aminopyridine improves clinical signs in multiple sclerosisAnnals of Neurology, 1987
- Treatment with oral 4‐aminopyridine in disorders of neuromuscular transmissionNeurology, 1981